PA Biotechnology develops in vitro irritation test kits for various industries. These kits provide an alternative to animal testing by enabling companies to assess product safety and compliance more efficiently.
Funding
$30K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional animal testing for product safety and compliance is costly, time-consuming, and raises ethical concerns. These methods often lack human relevance and can produce results that are difficult to extrapolate to human safety.
Solution
PA Biotechnology develops and provides in vitro irritation and toxicity test kits as an alternative to animal testing. These kits utilize advanced biotechnological methods to create reliable and ethical solutions for assessing product safety. The company's in vitro tissue and disease models enhance sustainability and innovation in research and development processes. PA Biotechnology's services include cytotoxicity testing, skin irritation testing, and custom in vitro model development, offering a comprehensive suite of tools for various industries.
Target Audience
The primary customers are companies in the cosmetics, pharmaceutical, and chemical industries seeking efficient, ethical, and reliable methods for product safety assessment and regulatory compliance.
Features
- In vitro skin irritation testing services
- Cytotoxicity testing services
- Custom in vitro model development
- In Vitro Skin Wound Healing (Scratch) Assay
- In Vitro Diabetic Wound Healing Assay
- OECD 431: In Vitro Skin Corrosion Test
- OECD 498: In Vitro Phototoxicity Test Using the RhE Method
- Genotoxicity Testing Service
- Phototoxicity Testing Services